Epidemiologic studies have revealed a tremendous increase in the prevalence of adrenal associated disease and related mortality worldwide. In order to meet all the therapeutic challenges in adrenal disease in China, CASE was founded in 2020. The objective of CASE is to launch an adrenal disease management model based on the Internet health information platform which allows the application and evaluation of adrenal disease treatment strategies at multiple centers. The proprietary electronic medical database will help the dynamic big-data analysis in epidemiology of adrenal disease, diagnosis, and treatment.
In order to meet all the challenges in the diagnosis and treatment of adrenal diseases in China, CASE was founded in 2020. With advanced medical equipment and Internet of Things (IoT) technology, CASE is committed to creating an online and offline integrated solution for adrenal disease, and for the entire spectrum of adrenal disease, to achieve a more convenient and precise model of care for patients, aiming to establish a platform with diagnosis and treatment of adrenal disease and their long-term follow-up. It allows the application and evaluation of treatment strategies at these centers.
Study Type
OBSERVATIONAL
Enrollment
2,000
Endocrinology
Shanghai, China
RECRUITINGPercentage of adrenal diseases in China
Time frame: through study completion, an average of 1 year
Number of participants with complication of adrenal diseases in China
Time frame: through study completion, an average of 1 year
concentration of aldosterone
Time frame: through study completion, an average of 1 year
concentration of cortisol
Time frame: through study completion, an average of 1 year
concentration of urine cortisol
Time frame: through study completion, an average of 1 year
concentration of androstenedione
Time frame: through study completion, an average of 1 year
concentration of adrenocorticotropic hormone
Time frame: through study completion, an average of 1 year
concentration of 17-hydroxyprogesterone
Time frame: through study completion, an average of 1 year
concentration of metanephrines
Time frame: through study completion, an average of 1 year
changes in adrenal CT
Time frame: through study completion, an average of 1 year
percentage of hypoadrenalism
Time frame: through study completion, an average of 1 year
Mental health status
The symptom checklist-90 will be used to evaluate the changes of participants' psychological state through study completion from 10 aspects, including somatization, obsessive-compulsive symptoms, interpersonal sensitivity, depression, anxiety, hostility, terror, paranoia, psychotic and others.
Time frame: through study completion, an average of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.